O1‐02‐06: ABBV‐8E12, A HUMANIZED ANTI‐TAU MONOCLONAL ANTIBODY FOR THE TREATMENT OF EARLY ALZHEIMER'S DISEASE: STUDY DESIGN AND BASELINE CHARACTERISTICS FOR A 96‐WEEK, MULTIPLE DOSE, RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED PHASE 2 STUDY. (1st July 2006) - Florian, Hana; Budur, Kumar; Wang, Deli; Robieson, Weining Z.; Soares, Holly; Braunstein, Joel B.; Holtzman, Dave M.; Bateman, Randall J.; Rendenbach-Mueller, Beatrice; Mendonca, Nuno